Cite
MLA Citation
Graham P. Collins et al.. “A Phase II Study to Assess the Safety and Efficacy of the Dual mTORC1/2 and PI3K Inhibitor Bimiralisib (PQR309) in Relapsed, Refractory Lymphoma.” HemaSphere, vol. 5, no. 11, 2021, pp. e656–. http://access.bl.uk/ark:/81055/vdc_100145485964.0x000007